Celgene Reports First Quarter 2012 Operating and Financial Results

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) reported Non-GAAP net product sales of $1,245 million for the first quarter of 2012, a 17 percent increase from the same period in 201…
Read the full story: BioSpace.com Featured News